PROVIDER PROFILE · NPI 1124229869

Mahakit Inklab

Hematology-OncologySunnyside, WAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$201K

Distinct drugs

Brand share

61.7%

Top prescribed drugs

Apixaban29 claims

Letrozole22 claims

Rivaroxaban17 claims

Anastrozole14 claims

Enzalutamide12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

Top paying entities

Food and Beverage$1K

REFERRAL NETWORK

Where Mahakit Inklab's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Maria Moore Hematology-Oncology · Clyde, NC	73	561
JACKSON COUNTY MEMORIAL HOSPITAL AUTHORITY	56	221
NEWMAN, JAMES	16	47

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Maria Moore Hematology-Oncology · Clyde, NC	76	246
COMANCHE COUNTY HOSPITAL AUTHORITY	52	349
JACKSON COUNTY MEMORIAL HOSPITAL AUTHORITY	12	43

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history